- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Depressive Disorder in Finland
Total 3443 results
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMajor Depressive DisorderUnited States
-
SunovionCompletedMajor Depressive Disorder With Mixed FeaturesUnited States, Serbia, Ukraine, Russian Federation, United Kingdom
-
LivaNovaRecruiting
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderUnited States, Canada
-
Turku University HospitalUniversity of TurkuCompletedDepression | Sleep Disturbance | Prolonged PregnancyFinland
-
COMPASS PathwaysRecruitingTreatment Resistant DepressionUnited States, Spain, Ireland, France, United Kingdom, Canada, Sweden
-
Janssen Research & Development, LLCCompletedMajor Depressive Disorder With Anxious DistressUnited States, Moldova, Republic of, Russian Federation, Ukraine, United Kingdom
-
Janssen-Cilag Ltd.Active, not recruitingDepressive Disorder, MajorTaiwan, Turkey, Malaysia, Germany, Czechia, Korea, Republic of, Poland, Hungary, Argentina, Belgium, Bulgaria, Finland, Greece, South Africa
-
University of PittsburghNational Institute of Mental Health (NIMH)Completed
-
GlaxoSmithKlineTerminatedDepressive Disorder, MajorUnited States, Canada
-
Women and Infants Hospital of Rhode IslandNational Institute on Drug Abuse (NIDA)CompletedPerinatal Depression, Substance UseUnited States
-
AstraZenecaCompletedMajor Depressive DisorderKorea, Republic of, Mexico, South Africa, China, Finland, Canada, Spain, Philippines, Malaysia
-
University of OuluOulu University Hospital; University of Eastern Finland; ODL Terveys Oy; Valkee OyUnknownSeasonal Affective DisorderFinland
-
Boston Medical CenterCompleted
-
Forest LaboratoriesCompletedDepression | Major Depressive DisorderUnited States, Canada
-
AstraZenecaCompletedMajor Depressive DisorderUnited States
-
Janssen Research & Development, LLCCompletedDepressive Disorder, Treatment-ResistantUnited States, France, Belgium, Spain, Poland, Bulgaria, South Africa, Finland, Brazil, Sweden, United Kingdom, Lithuania
-
Biohaven Therapeutics Ltd.RecruitingMajor Depressive DisorderUnited States
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderUnited Kingdom, United States, Belgium, Austria, Australia, Germany, Sweden
-
PfizerCompletedMajor Depressive DisorderUnited States
-
Sirtsei Pharmaceuticals, Inc.CompletedMajor Depressive DisorderUnited States
-
Forest LaboratoriesCompletedMajor Depressive DisorderUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDepressive Disorder, MajorBelgium, Germany, France, Slovakia, Czech Republic, Finland
-
H. Lundbeck A/SOtsuka Pharmaceutical Co., Ltd.CompletedMajor Depressive DisorderFinland, Sweden, Estonia, Bulgaria, United States, Canada, Germany, Korea, Republic of, Latvia, Lithuania, Mexico, Poland, Romania, Russian Federation, Ukraine, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerPfizerCompletedStudy Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive DisorderMajor Depressive DisorderUnited States
-
Eli Lilly and CompanyCompletedDepressive Disorder, MajorUnited States, Finland, Poland, Russian Federation, Argentina
-
Women and Infants Hospital of Rhode IslandNational Institute of Mental Health (NIMH)CompletedDepression | Depression, PostpartumUnited States
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
ACADIA Pharmaceuticals Inc.CompletedAdjunctive Treatment of Major Depressive DisorderUnited States, Serbia, Finland, Poland, Russian Federation, Ukraine, United Kingdom, Slovakia, South Africa
-
Euthymics BioScience, Inc.CompletedMajor Depressive DisorderUnited States
-
Janssen Research & Development, LLCCompletedTreatment-resistant DepressionUnited States, France, Belgium, Mexico, Canada, Brazil, Estonia, Hungary, Slovakia
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorUnited States, Bulgaria, Ukraine, Russian Federation, Germany, Finland, Japan, France
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderUnited States, Puerto Rico
-
Assurex Health Inc.University of MichiganCompletedMajor Depressive Disorder (MDD)United States
-
University of OuluOulu University Hospital; University of Eastern Finland; ODL Terveys Oy; Valkee OyCompleted
-
PfizerCompleted
-
Bristol-Myers SquibbCompletedMajor Depressive DisorderUnited States
-
AstraZenecaCompletedMajor Depressive DisorderUnited States
-
AbbVieCompletedMajor Depressive DisorderUnited States, Canada, Czechia, Finland, Poland, Puerto Rico, Serbia, Slovakia
-
Sumitomo Pharma America, Inc.TerminatedDepressive Episodes, Bipolar I DepressionUnited States, Bulgaria, Japan, Romania, Canada, Slovakia
-
ACADIA Pharmaceuticals Inc.CompletedAdjunctive Treatment of Major Depressive DisorderUnited States
-
AstraZenecaTargacept Inc.CompletedDepression | Major Depressive DisorderSweden, Czech Republic, Poland, Germany, Estonia, Latvia, Lithuania, Finland, France, Hungary
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Pharmaceutical Co., Ltd.CompletedAnxiety | Major Depressive DisorderUnited States
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderUnited States, Puerto Rico
-
Relmada Therapeutics, Inc.RecruitingDepression | Major Depressive DisorderUnited States
-
ShireCompletedMajor Depressive DisorderUnited States, Germany, Sweden, Poland, South Africa, Belgium, Czechia, Estonia, Finland, Hungary, Romania
-
TakedaCompletedMajor Depressive DisorderUnited States
-
Forest LaboratoriesCompletedMajor Depressive DisorderUnited States, Canada
-
Forest LaboratoriesCompletedMajor Depressive DisorderUnited States, Canada